Effect of propolis in the treatment of experimental Staphylococcus aureus Keratitis in Rabbits

Ophthalmic Research

Volumn 37, Issue 6, 2005, Pages 328-334

  Oksuz, H ^a,b   Duran, N ^a   Tamer, C ^a   Cetin, M ^a   Silici, S ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Flavones; Keratitis, experimental; Propolis; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CIPROFLOXACIN; PHOSPHATE BUFFERED SALINE; PROPOLIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BEE EXTRACT; CONTROLLED STUDY; CORNEA OPACITY; DRUG EFFECT; HONEYBEE; KERATITIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SLIT LAMP; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CORNEAL ULCER; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; EYE INFECTIONS, BACTERIAL; PROPOLIS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 27344439868     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087943     Document Type: Article

References (36)

1. Alexandrakis G, Alfanso EC, Miller D: Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000;107:1497-1502.
2. Asbell P, Stenson S: Ulcerative keratitis. Survey of thirty years laboratory experience. Arch Ophthalmol 1982;100:77-80.
3. Liesegang TJ: Bacterial and fungal keratitis; in Kaufman HE, Baron BA, McDonald MB (eds): The Cornea 2. Boston, Butterworth-Heinemann, 1998, pp 159-219.
4. Goldstein MH, Kowalski RP, Gordon YJ: Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 1999;106:1313-1318.
5. Maffett M, O'Day DM: Ciprofloxacin-resistant bacterial keratitis. Am J Ophthalmol 1993;115:545-546.
6. Walsh TR, Howe RA: The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu Rev Microbiol 2002;56:657-675.
7. Trinkaus-Randall V, Leibowitz HM, Ryan WJ, Kupferman A: Quantification of stromal destruction in the inflamed cornea. Invest Ophthalmol Vis Sci 1991;32:603-609.
8. Gritz DC, Lee TY, Kwitko S, McDonnell PJ: Topical anti-inflammatory agents in an animal model of microbial keratitis. Arch Ophthalmol 1990;108:1001-1005.
9. Dobrowolski JW, Vohora SB, Sharma K, Shah SA, Naqvi SA, Dandiya PC: Antibacterial, antifungal, antiamoebic, anti-inflammatory, and antipyretic studies on propolis bee products. J Ethnopharmacol 1991;35:77-82.
10. Khayyal MT, el-Ghazaly MA, el-Khatip AS: Mechanisms involved in the anti-inflammatory effect of propolis extract. Drugs Exp Clin Res 19993;19:197-203.
11. Strehl E, Volpert R, Elstner EF: Biochemical activities of propolis extracts. III. Inhibition of dehydrofolate reductase. Z Naturforsch 1994;49:39-43.
12. Volpert R, Elstner EF: Interactions of different extracts of propolis with leucocytes and leucocytic enzymes. Arzneimittelforschung 1996;46:47-51.
13. Mirzoeva OK, Calder PC: The effect of propolis and its components on eicosanoid production during the inflammatory response. Protaglandins Leukot Essent Fatty Acids 1996;55:441-449.
14. Krol W, Czuba Z, Scheller S, Gabrys J, Grabiec S, Shani J: Anti-oxidant property of etanolic extract of propolis (EEP) evaluated by inhibiting the chemiluminescence oxidation of luminol. Biochem Int 1990;21:593-597.
15. Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD: Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 1993;329:21-24.
16. Pascual C, Gonzales R, Torricella RG: Scavenging action of propolis extract against oxygen radicals. J Ethnopharmacol 1994;41:9-13.
17. Scheller S, Krol W, Swiacik J, Owczarek S, Gabrys J, Shani J: Antitumoral property of ethanolic extract of propolis in mice-bearing Ehrlich carcinoma, as compared to bleomycin. Z Naturforsch [C] 1989;44:1063-1065.
18. Grunberger D, Banerjee R, Eisinger K, Oltz EM, Efros L, Estevez V, Nakanishi K: Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 1988;44:230-2322.
19. Marcucci MC: Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 1995;26:83-99.
20. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard: M7-A4. Villanova, National Committee for Clinical Laboratory Standards, 1997.
21. Beisel KW, Hazlett LD, Berk RS: Dominant susceptibility effect on the murine corneal response to Pseudomonas aeruginosa. Proc Soc Exp Biol Med 1983;172:488-491.
22. Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF: Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996;122:1-17.
23. Pushker N, Dada T, Sony P, Ray M, Agarwal T, Vajpayee RB: Microbial keratitis after laser in situ keratomileusis. J Refract Surg 2002;18:280-286.
24. Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN: Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991;98:639-650.
25. Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y: Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 2001;85:842-847.
26. Chusid MJ, Davis SD: Experimental keratitis in neutropenic guinea pigs: polymorphonuclear leukoytes in corneal host defense. Infect Immun 1979;24:948-952.
27. Elgebaly SA, Miano DC, Kreutzer DL, Fishman JB: Cornea derived neutrophil chemotactic factors: intracellular synthesis and release. Curr Eye Res 1990;9:839-845.
28. Leibowitz HM, Ryan WJ, Kupferman A, Desantis L: Effect of concurrent topical corticosteroid and NSAI therapy of experimental keratitis. Invest Opththalmol Vis Sci 1986;27:1226-1229.
29. Vajpayee RB, Sharma N, Chand M, Tabin GC, Vajpayee M, Anand JR: Corneal superinfection in acute hemorrhagic conjunctivitis. Cornea 1998;17:614-617.
30. Marcucci MC, De Camargo FA, Lopes CMA: Identification of amino acids in Brazilian propolis. Z Naturforsch [C] 1996;51:11-14.
31. Bankova V, Christov R, Kujumgiev A, Marcucci MC, Popov S: Chemical composition and antibacterial activity of Brazilian propolis. Z Naturforsch [C] 1995;50:167-172.
32. Burdock GA: Review of the biological properties and toxicity of bee propolis. Food Chem Toxicol 1998;36:347-363.
33. Krol W, Scheller S, Shani J, Pietsz G, Czuba Z: Synergistic effect of ethanolic extract of propolis and antibiotics on the growth of Staphylococcus aureus. Arzneimittelforschung 1993;43:607-609.
34. Focht J, Hansen SH, Nielsen J V, Berg-Segers A, Riezler R: Bacterial effect of propolis in vitro against agents causing upper respiratory tract infections. Arzneimittelforschung 1993;43:921-923.
35. Strehl E, Volpert R, Elstner EF: Biochemical activities of propolis extracts. III. Inhibition of dehydrofolate reductase. Z Naturforsch 1994;49:39-43.
36. Callegan MC, Hobden JA, Hill JM, Insler MS, O'Callaghan RJ: Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci 1992;33:3017-3023.